Anti-VEGF Agents: Conquering Retinal Disease at DLEI

Anti-VEGF Therapy is a revolutionary development in the treatment of many Retinal disorders that are associated with abnormal growth of blood vessels. VEGF, or Vascular Endothelial Growth Factor, is a protein that occurs naturally in the body and induces the growth of new blood vessels. In some eye diseases, this process, however, becomes out-of-control and destructive, resulting in leakage of fluid, bleeding, and loss of vision. Anti-VEGF injections prevent VEGF from functioning, thus stopping this abnormal growth and preserving your vision.

At Dada Laser Eye Institute (DLEI), we provide advanced intravitreal anti-VEGF treatment for Retinal diseases including:

• Diabetic Retinopathy 
• Wet Age-Related Macular Degeneration (AMD)
• Retinal Vein Occlusions
• Myopic Macular Degeneration

How Anti-VEGF Therapy Works

This Therapy is administered by injecting a specific drug—usually Ranibizumab, Aflibercept, or Bevacizumab—straight into the vitreous space of the eye. Under aseptic conditions, the drug prevents the action of VEGF by binding to it. This has the following effects:

• Less leakage of liquid into the Retina
• Shrinkage of Pathological blood vessels
• Avoidance or slowing of vision deterioration

Advantages of Anti-VEGF Therapy

• Slows disease progression significantly
• Can enhance visual acuity in most instances
• Minimally Invasive and conducted under topical Anesthesia
• Secure and comfortable in DLEI’s state-of-the-art operation rooms

Treatment plans for each patient are tailored, frequently requiring several sessions depending on how they react. Our Retina experts combine advanced diagnostic equipment such as OCT imaging with experienced surveillance in order to achieve the optimal visual results.

DLEI is committed to restoring and maintaining your vision with the newest anti-VEGF treatments, administered with empathy and clinical distinction.